Home/Filings/4/0000899243-22-009382
4//SEC Filing

Gutierrez-Esteinou Rolando 4

Accession 0000899243-22-009382

CIK 0001840904other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:04 PM ET

Size

5.5 KB

Accession

0000899243-22-009382

Insider Transaction Report

Form 4
Period: 2022-03-02
Gutierrez-Esteinou Rolando
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2022-03-02+206,950206,950 total
    Exercise: $5.65Exp: 2032-03-01Common Shares (206,950 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1
  • filerCIK 0001860581

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:04 PM ET
Size
5.5 KB